Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2012 Feb;54(2):113-21.
doi: 10.1007/s00234-011-0854-2. Epub 2011 Mar 22.

Factors affecting brain structure in men with HIV disease in the post-HAART era

James T Becker  1 , Victoria Maruca, Lawrence A Kingsley, Joanne M Sanders, Jeffery R Alger, Peter B Barker, Karl Goodkin, Eileen Martin, Eric N Miller, Ann Ragin, Ned Sacktor, Ola Selnes; Multicenter AIDS Cohort Study
Collaborators, Affiliations
Multicenter Study

Factors affecting brain structure in men with HIV disease in the post-HAART era

James T Becker et al. Neuroradiology. 2012 Feb.

Abstract

Introduction: The purpose of this study was to characterize brain volumetric differences in HIV seropositive and seronegative men and to determine effects of age, cardiovascular risk, and HIV infection on structural integrity.

Methods: Magnetic resonance imaging was used to acquire high-resolution neuroanatomic data in 160 men aged 50 years and over, including 84 HIV seropositive and 76 seronegative controls. Voxel-based morphometry was used to derive volumetric measurements at the level of the individual voxel. Data from a detailed neuropsychological test battery were recombined into four summary scores representing psychomotor speed, visual memory, verbal memory, and verbal fluency.

Results: Both age and HIV status had a significant effect on both gray matter (GM) and white matter (WM) volume. The age-related GM atrophy was primarily in the superior temporal and inferior frontal regions; the HIV-related GM loss included the posterior and inferior temporal lobes, the parietal lobes, and the cerebellum. Among all subjects, the performance on neuropsychological tests, as indexed by a summary variable, was related to the volume of both the GM and WM. Contrary to our predictions, the CVD variables were not linked to brain volume in statistically adjusted models.

Conclusion: In the post-HAART era, having HIV infection is still linked to atrophy in both GM and WM. Secondly, advancing age, even in this relatively young cohort, is also linked to changes in GM and WM volume. Thirdly, CNS structural integrity is associated with overall cognitive functions, regardless of the HIV infection status of the study volunteers.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Dr. Miller is the author of the CalCAP reaction time program and has a financial interest in this software.

Figures

Fig. 1
Fig. 1
The results of the VBM analysis of gray matter projected onto the single-subject template of the cortical surface from SPM2. The effects of age are shown in the right-hand columns, and the effects of HIV disease in the left-hand columns. Both variables were entered into the same analysis simultaneously, with total intra-cranial volume as a covariate. False discovery rate=p<.05, with an extent threshold of 100 voxels. The regions with the hotter colors are those with the greatest amount of atrophy attributable to age or HIV status
Fig. 2
Fig. 2
The results of the VBM analysis of the white matter atrophy projected onto the mean whole brain image created from the seronegative subjects. For all study participants, atrophy was significantly associated with advancing age, but not with HIV status. False discovery rate=p<.05, with an extent threshold of 100 voxels. The regions with the hotter colors are those with the greatest amount of white matter atrophy attributable to age
Fig. 3
Fig. 3
WM atrophy associated with lower scores on the neuropsychological tests. These regions were in the same WM regions as those observed for the aging effect, but with less spatial extent. The left-hand image shows a “glass brain” view in which all voxels are visible in each of the three perspectives. The images on the right show the areas of significant association between white matter volume and test performance
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology. 1992;42:1472–1476. - PubMed
    1. Chiesi A, Vella S, Dally LG, Pedersen C, Danner S, Johnson AM, Schwander S, Goebel FD, Glauser M, Antunes F, Lundgren JD. Epidemiology of AIDS dementia complex in Europe. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:39–44. - PubMed
    1. Stoff DM. Mental health research in HIV/AIDS and aging: problems and prospects. AIDS. 2004;18(Suppl 1):3–10. - PubMed
    1. Valcour V, Shikuma C, Shiramizu B, Watters M, Puff P, Selnes O, Holck P, Grove J, Sacktor N. Higher frequency of dementia in older HIV-1 individuals. Neurology. 2004;63:822–827. - PMC - PubMed
    1. Valcour CG, Shikuma CM, Watters MR, Sacktor NC. Cognitive impairment in older HIV1-seropositive individuals: prevalence and potential mechanisms. AIDS. 2004;18(Suppl 1):79–86. - PMC - PubMed

Publication types